Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Developing sustainable funding for vaccine safety infrastructure.
Black, S; MULHOLLAND, K; Halsey, NA;
2009
Vaccine, (2009).28 5 10.1016/j.vaccine.2009.11.034.
Complex cytokine profiles induced by BCG vaccination in UK infants.
Lalor, MK; SMITH, SG; FLOYD, S; GORAK-STOLINSKA, P; Weir, RE; BLITZ, R; BRANSON, K; FINE, PE; DOCKRELL, HM;
2009
Vaccine, (2009).28 6 10.1016/j.vaccine.2009.11.004.
The burden of hospitalised rotavirus infections in Fiji.
Jenney, A; Tikoduadua, L; Buadromo, E; Barnes, G; Kirkwood, CD; Boniface, K; Bines, J; MULHOLLAND, K; Russell, F;
2009
Vaccine, (2009).27 Sup SUPPL. 10.1016/j.vaccine.2009.08.071.
Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Waitumbi, JN; Anyona, SB; Hunja, CW; Kifude, CM; Polhemus, ME; Walsh, DS; Ockenhouse, CF; Heppner, DG; Leach, A; Lievens, M; Ballou, WR; Cohen, JD; SUTHERLAND, CJ;
2009
PloS one, (2009).4 11 10.1371/journal.pone.0007849.
Bluetongue vaccines.
Noad, R; ROY, P;
2009
Vaccine, (2009).27 Sup SUPPL. 10.1016/j.vaccine.2009.08.037.
Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance.
Nokes, DJ; Ngama, M; Bett, A; Abwao, J; Munywoki, P; English, M; SCOTT, JA G; Cane, PA; MEDLEY, GF;
2009
Clinical infectious diseases, (2009).49 9 10.1086/606055.
Cost-effectiveness of rotavirus vaccination in peru.
CLARK, AD; Walker, DG; Mosqueira, NR; Penny, ME; Lanata, CF; Fox-Rushby, J; SANDERSON, CF B;
2009
The Journal of infectious diseases, (2009).200 Su s1 10.1086/605043.
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
Cheung, Y-B; ZAMAN, SM A; Nsekpong, ED; Van Beneden, CA; Adegbola, RA; GREENWOOD, B; CUTTS, FT;
2009
The Pediatric infectious disease journal, (2009).28 11 10.1097/INF.0b013e3181a78185.
Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.
Stewart, M; Bhatia, Y; Athmaran, TN; Noad, R; Gastaldi, C; Dubois, E; Russo, P; Thiéry, R; Sailleau, C; Bréard, E; Zientara, S; ROY, P;
2009
Vaccine, (2009).28 17 10.1016/j.vaccine.2009.10.072.
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
Sirima, SB; Tiono, AB; Ouédraogo, A; Diarra, A; Ouédraogo, AL; Yaro, JB; Ouédraogo, E; Gansané, A; Bougouma, EC; Konaté, AT; Kaboré, Y; Traoré, A; Chilengi, R; Soulama, I; Luty, AJ F; Druilhe, P; COUSENS, S; Nébié, I;
2009
PloS one, (2009).4 10 10.1371/journal.pone.0007549.